Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Baxter Completes Acquisition of Hillrom, Creating ~$15 Billion Global Medtech Leader
Life Sciences Times
-
December 13, 2021
0
Venture Capital
Ascensus Expands Fine Chemicals Production Capabilities for Life Sciences with Acquisition of Wychem
Life Sciences Times
-
December 13, 2021
0
Venture Capital
Accellix Raises $10 Million From BroadOak Capital Partners
Life Sciences Times
-
December 13, 2021
0
Venture Capital
Organon Completes Acquisition of Forendo Pharma
Life Sciences Times
-
December 13, 2021
0
Venture Capital
Cross-Border Impact Ventures Launches New Impact Fund with Commitments of US$30 Million
Life Sciences Times
-
December 10, 2021
0
Venture Capital
Whitecap Venture Partners Launches New $140 Million Early-Stage Venture Capital Fund
Life Sciences Times
-
December 9, 2021
0
Venture Capital
Exai Bio Secures $67.5 Million Series A Financing to Advance Next-Generation, RNA-Based Liquid Biopsy Platform for Early Cancer Detection
Life Sciences Times
-
December 9, 2021
0
Venture Capital
Cvent Lists on the Nasdaq as “CVT” After Announcing Close of Business Combination with Dragoneer Growth Opportunities Corp. II
Life Sciences Times
-
December 9, 2021
0
Venture Capital
Avistone Pharmaceuticals Secures $200 Million Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital
Life Sciences Times
-
December 8, 2021
0
Venture Capital
Ranpak Expands Total Solution for Cold Chain Packaging with Acquisition of Recycold Cool Solutions BV, Makers of Cool Packs
Life Sciences Times
-
December 8, 2021
0
Venture Capital
Nomic Closes $17 Million Series A to Develop and Commercialize the World’s Highest Throughput Proteomic Platform
Life Sciences Times
-
December 8, 2021
0
Venture Capital
Xcovery Acquires Majority Controlling Stake in Meryx Pharmaceuticals
Life Sciences Times
-
December 7, 2021
0
1
...
91
92
93
...
115
Page 92 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026